Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-06-14

FDA Approved: SOLOSEC — Supplemental Application (Evofem Inc.)

View source ↗

Summary

The FDA approved a supplemental application for SOLOSEC (secnidazole) submitted by Evofem Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SOLOSEC (secnidazole)

Snippet

SUPPL AP for SOLOSEC (SECNIDAZOLE)